1.Blockade of the Dopamine D3 Receptor Attenuates Opioids-Induced Addictive Behaviours Associated with Inhibiting the Mesolimbic Dopamine System.
Rong-Rong HU ; Meng-Die YANG ; Xiao-Yan DING ; Ning WU ; Jin LI ; Rui SONG
Neuroscience Bulletin 2023;39(11):1655-1668
Opioid use disorder (OUD) has become a considerable global public health challenge; however, potential medications for the management of OUD that are effective, safe, and nonaddictive are not available. Accumulating preclinical evidence indicates that antagonists of the dopamine D3 receptor (D3R) have effects on addiction in different animal models. We have previously reported that YQA14, a D3R antagonist, exhibits very high affinity and selectivity for D3Rs over D2Rs, and is able to inhibit cocaine- or methamphetamine-induced reinforcement and reinstatement in self-administration tests. In the present study, our results illustrated that YQA14 dose-dependently reduced infusions under the fixed-ratio 2 procedure and lowered the breakpoint under the progressive-ratio procedure in heroin self-administered rats, also attenuated heroin-induced reinstatement of drug-seeking behavior. On the other hand, YQA14 not only reduced morphine-induced expression of conditioned place preference but also facilitated the extinguishing process in mice. Moreover, we elucidated that YQA14 attenuated opioid-induced reward or reinforcement mainly by inhibiting morphine-induced up-regulation of dopaminergic neuron activity in the ventral tegmental area and decreasing dopamine release in the nucleus accumbens with a fiber photometry recording system. These findings suggest that D3R might play a very important role in opioid addiction, and YQA14 may have pharmacotherapeutic potential in attenuating opioid-induced addictive behaviors dependent on the dopamine system.
Rats
;
Mice
;
Animals
;
Analgesics, Opioid
;
Dopamine
;
Heroin/pharmacology*
;
Dopamine Antagonists/pharmacology*
;
Receptors, Dopamine D3/metabolism*
;
Morphine/pharmacology*
;
Behavior, Addictive/drug therapy*
;
Self Administration
2.Mechanism of apoptosis-inducing effects of dopamine on K562 leukemia cells.
Lin-Bo YUAN ; Qun HE ; Yi-Min GUO
Journal of Zhejiang University. Medical sciences 2007;36(2):191-195
OBJECTIVETo investigate the mechanism of the apoptosis-inducing effects of dopamine on K562 leukemia cells.
METHODSK562 cells were treated with DP2785, the dopamine receptors were detected with fluorescence spectrophotometer, UV spectrophotometer and fluorescence microscope; the contents of cAMP in K562 cells were measured; and the subtypes of dopamine receptor on K562 cells were analyzed by receptor blocking.
RESULTThe existence of dopamine receptors in K562 cells was demonstrated by fluorescence microscopy, UV spectrophotometer and fluorescence spectrophotometer. Dopamine enhanced the contents of cAMP in K562 cells. Dopamine receptors were blocked by both D1 and D2 antagonists.
CONCLUSIOND1 and D2 dopamine receptors may be involved in dopamine-induced apoptosis of K562 cells, and dopamine can also increase the contents of cAMP in K562 cells.
Apoptosis ; drug effects ; Cyclic AMP ; metabolism ; Dopamine ; pharmacology ; Humans ; K562 Cells ; Microscopy, Fluorescence ; Receptors, Dopamine D1 ; metabolism ; Receptors, Dopamine D2 ; metabolism ; Spectrometry, Fluorescence ; Spectrophotometry, Ultraviolet
3.The measurement of tyrosine hydroxylase activity in the brain of conscious rats.
Wei WANG ; De-zhong ZHAO ; Wei-xia WANG ; Bin-hui SUN
China Journal of Chinese Materia Medica 2002;27(2):132-135
OBJECTIVETo set the measuring method of tyrosine hydroxylase activity in the brain of conscious rats.
METHODBy using microdialysis and High Performance Liquid Chromatography-Electrochemical Detector system, the 3, 4-dihydrioxphenylalanine (DOPA) formation in the striatum of 6-hydroxdopamine-pretreated rats during infusion of an L-aromatic amino-acid decarboxylase inhibitor (NSD1015) was monitored.
RESULTThe absence of DOPA in dialysates of 6-hydroxdopamine-pretreated rats, the measurable DOPA and the steady decreasing of 3,4-dihydroxyphenylacetic acid(DOPAC) during infusion of NSD1015 and the disappearance of DOPA after administration of alpha-methyl-rho-tyrosine indicated that the dialyzed DOPA was derived from dopaminergic nerve terminals. After intraperitoneal administration of dopamine receptor agonist apomorphine the DOPA output was deseased. After intraperitoneal administration of dopamine recepter antagonist haloperidol, the DOPA output was increased. The study showed that twenty-four hours ofter implantation of the probe with infusion of 0.01 mmol.L-1 NSD1015, the DOPA level in the striatum of 6-hydroxdopamine-pretreated rats was 0.39 +/- 0.12 pmol/min (X +/- S, n = 5).
CONCLUSIONThe DOPA concentration in striatal dialysates could be considered as an index of tyrosion hydroxlase activity during infusion of 0.01 mM NSD1015. The method in vivo to monitor tyrosine hydroxlase activity in the brain is reliable.
Animals ; Apomorphine ; pharmacology ; Brain ; enzymology ; Dihydroxyphenylalanine ; metabolism ; Dopamine Agonists ; pharmacology ; Dopamine Antagonists ; pharmacology ; Female ; Haloperidol ; pharmacology ; Male ; Microdialysis ; Rats ; Rats, Sprague-Dawley ; Tyrosine 3-Monooxygenase ; metabolism
4.Dopaminergic Neurons in the Ventral Tegmental-Prelimbic Pathway Promote the Emergence of Rats from Sevoflurane Anesthesia.
Yanping SONG ; Ruitong CHU ; Fuyang CAO ; Yanfeng WANG ; Yanhong LIU ; Jiangbei CAO ; Yongxin GUO ; Weidong MI ; Li TONG
Neuroscience Bulletin 2022;38(4):417-428
Dopaminergic neurons in the ventral tegmental area (VTA) play an important role in cognition, emergence from anesthesia, reward, and aversion, and their projection to the cortex is a crucial part of the "bottom-up" ascending activating system. The prelimbic cortex (PrL) is one of the important projection regions of the VTA. However, the roles of dopaminergic neurons in the VTA and the VTADA-PrL pathway under sevoflurane anesthesia in rats remain unclear. In this study, we found that intraperitoneal injection and local microinjection of a dopamine D1 receptor agonist (Chloro-APB) into the PrL had an emergence-promoting effect on sevoflurane anesthesia in rats, while injection of a dopamine D1 receptor antagonist (SCH23390) deepened anesthesia. The results of chemogenetics combined with microinjection and optogenetics showed that activating the VTADA-PrL pathway prolonged the induction time and shortened the emergence time of anesthesia. These results demonstrate that the dopaminergic system in the VTA has an emergence-promoting effect and that the bottom-up VTADA-PrL pathway facilitates emergence from sevoflurane anesthesia.
Anesthesia
;
Animals
;
Dopaminergic Neurons/metabolism*
;
Rats
;
Receptors, Dopamine D1/metabolism*
;
Sevoflurane/pharmacology*
;
Ventral Tegmental Area/metabolism*
5.Effects and mechanisms of low concentration dopamine on hydrogen peroxide-induced apoptosis in cultured neonatal rat cardiomyocytes.
Xiao-na CAI ; Sa SHI ; Hong-zhu LI ; Wang LI-NA ; Hong LI
Chinese Journal of Applied Physiology 2015;31(1):67-71
OBJECTIVETo study the effects of low concentration dopamine(DA) on hydrogen peroxide-induced apoptosis in cultured rat cardiomyocytes as well as the possible molecular mechanisms.
METHODSCultured neonatal rat cardiomyocytes were randomly divided into the following groups: control group (control), hydrogen peroxide group (H2O2), pretreated with low concentration dopamine ( DA + H2O2), dopamine receptor l(DR1) antagonist group (DR1 + DA + H2O2), dopamine receptor 2(DR2) antagonist group (DR2 + DA + H2O2). The cell apoptosis was then assessed by MTT and flow cytometry. The cellular ultrastructure changes were observed by transmission electron micro- scope. The activity of lactate dehydrogenase(LDH )and superoxide dismutase (SOD) in cell medium was analyzed by colorimetry. The protein expressions of Cytochrone c, Caspase 3 and Caspase 9 were obtained by Western blot.
RESULTSCompared with hydrogen peroxide group, low concentration dopamine(10 µmol/L) decreased the apoptosis rate and the expression of protein of apoptosis related protein, enhanced SOD activity, decreased LDH activity. DR1 antagonist SCH-23390 treatment inhibited dopamine induced cardiac protective effect. DR2 antagonist haloperido treatment had no changes compared with dopamine group.
CONCLUSIONAbove findings indicate that low concentration dopanine inhibits apoptosis induced by hydrogen peroxide in neonatal rat cardiomyocytes, which is partly associated with the activation of DR1.
Animals ; Apoptosis ; Benzazepines ; Caspase 3 ; metabolism ; Caspase 9 ; metabolism ; Cells, Cultured ; Dopamine ; pharmacology ; Hydrogen Peroxide ; L-Lactate Dehydrogenase ; metabolism ; Myocytes, Cardiac ; drug effects ; Rats ; Rats, Wistar ; Receptors, Dopamine D1 ; metabolism ; Superoxide Dismutase ; metabolism
6.Effects of pyrethroids on dopamine and its metabolites in nigrostriatum of male rats.
Gong-ping LIU ; Nian SHI ; Jun-hua LIANG ; Liang CHEN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2004;22(5):368-370
OBJECTIVETo investigate the effects of pyrethroids on nigrostriatal dopaminergic pathways in male rats and its mechanism.
METHODSDifferent doses of permethrin (PM, 200, 400 mg/kg) and deltamethrin (DM, 6.25, 12.50 mg/kg) in corn oil were administered to rats by gavage once daily for ten days, then the contents of dopamine (DA) and its metabolites, 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the substantial nigra and striatum were analyzed by HPLC-fluorescence detection.
RESULTSThe contents of DA in striatum in four administered groups were decreased to a certain extent. DA in 6.25 mg/kg DM group [(6.14 +/- 0.57) microg/g wet weight] was lower than that in control group [(9.46 +/- 1.95) microg/g wet weight], P < 0.05. The turnover rate of DA in 200, 400 mg/kg PM and 6.25, 12.5 mg/kg DM groups increased by 133.33%, 166.67%, 166.67%, 266.67% respectively (P < 0.05 or P < 0.01), however there was no significant difference in DA and DOPAC in substantial nigra between control and administered groups.
CONCLUSIONDM may inhibit tyrosine hydroxylase and decrease the level of DA in striatum, and both pyrethroid pesticides may increase the metabolism of dopamine in striatum.
3,4-Dihydroxyphenylacetic Acid ; metabolism ; Animals ; Chromatography, High Pressure Liquid ; Corpus Striatum ; drug effects ; metabolism ; Dopamine ; metabolism ; Homovanillic Acid ; metabolism ; Insecticides ; pharmacology ; Male ; Nitriles ; pharmacology ; Permethrin ; pharmacology ; Pyrethrins ; pharmacology ; Rats ; Rats, Sprague-Dawley ; Substantia Nigra ; drug effects ; metabolism
7.Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers.
He Jin LEE ; Sung Min BAEK ; Dong Hwan HO ; Ji Eun SUK ; Eun Duk CHO ; Seung Jae LEE
Experimental & Molecular Medicine 2011;43(4):216-222
Parkinson's disease (PD) is characterized by selective and progressive degeneration of dopamine (DA)-producing neurons in the substantia nigra pars compacta (SNpc) and by abnormal aggregation of alpha-synuclein. Previous studies have suggested that DA can interact with alpha-synuclein, thus modulating the aggregation process of this protein; this interaction may account for the selective vulnerability of DA neurons in patients with PD. However, the relationship between DA and alpha-synuclein, and the role in progressive degeneration of DA neurons remains elusive. We have shown that in the presence of DA, recombinant human alpha-synuclein produces non-fibrillar, SDS-resistant oligomers, while beta-sheet-rich fibril formation is inhibited. Pharmacologic elevation of the cytoplasmic DA level increased the formation of SDS-resistant oligomers in DA-producing neuronal cells. DA promoted alpha-synuclein oligomerization in intracellular vesicles, but not in the cytosol. Furthermore, elevation of DA levels increased secretion of alpha-synuclein oligomers to the extracellular space, but the secretion of monomers was not changed. DA-induced secretion of alpha-synuclein oligomers may contribute to the progressive loss of the dopaminergic neuronal population and the pronounced neuroinflammation observed in the SNpc in patients with PD.
Blotting, Western
;
Cell Line, Tumor
;
Dopamine/*metabolism
;
Humans
;
Levodopa/pharmacology
;
Neurons/*metabolism/pathology/*secretion
;
Parkinson Disease/metabolism/pathology
;
Substantia Nigra/metabolism/pathology
;
alpha-Synuclein/*biosynthesis/*secretion
8.Influence of GnRH Agonist and Neural Antagonists on Stress-blockade of LH and Prolactin Surges Induced by 17 beta-estradiol in Ovariectomized Rats.
Kyung Yoon KAM ; Yong Bin PARK ; Min Seok CHEON ; Sang Soo KANG ; Kyungjin KIM ; Kyungza RYU
Yonsei Medical Journal 2002;43(4):482-490
In our previous study, we demonstrated that immobilization stress blocked estrogen-induced luteinizing hormone(LH) surge possibly by inhibiting the synthesis and release of gonadotropin-releasing hormone (GnRH) at the hypothalamic level and by blocking estrogen-induced prolactin (PRL) surge by increasing the synthesis of dopamine receptor at the pituitary level in ovariectomized rats. The present study was performed to determine whether immobilization stress affects pituitary LH responsiveness to GnRH, and whether endogenous opioid peptide (EOP) and dopamine systems are involved in blocking LH and PRL surges during immobilization stress. Immobilization stress was found to inhibit basal LH release and to completely abolish LH surge. However, the intravenous application of GnRH agonist completely restored immobilization-blocked LH surge and basal LH release. Treatment with naloxone did not exert any effect on immobilization-blocked LH surge but increased basal LH release during immobilization stress. Pimozide did not affect immobilization-blocked LH surge or basal LH release. Naloxone also decreased immobilization-induced basal PRL release, but had no effect on immobilization-blocked PRL surge. Immobilization-increased basal PRL levels were augmented by pimozide treatment and immobilization-blocked PRL surge was dramatically restored by pimozide. We conclude that immobilization stress does not impair pituitary LH response to GnRH, and that the immobilization stress-induced blockage of LH surge is probably not mediated by either the opioidergic or the dopaminergic system. However, immobilization-blockade of PRL surge may be partly mediated by the dopaminergic system.
Animal
;
Estradiol/*pharmacology
;
Female
;
Gonadorelin/*pharmacology
;
Immobilization
;
Luteinizing Hormone/*secretion
;
Naloxone/pharmacology
;
Opioid Peptides/physiology
;
Ovariectomy
;
Prolactin/*secretion
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Dopamine/physiology
;
Stress/*metabolism
9.Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.
You HE ; Lei-Ping YU ; Guo-Zhang JIN
Neuroscience Bulletin 2009;25(2):43-53
OBJECTIVETo explore the possible differential trafficking properties of the dopamine D1-like receptor subtypes, D1 receptor and D5 receptor.
METHODSTo visualize distributions of dopamine D1-like receptor subtypes at subcellular level, the yellow and cyan variants of green fluorescent protein (GFP) were used to tag D1 and D5 receptors. After transfection with the tagged dopamine receptors, the neuroblastoma cells NG108-15 were treated with D1 agonist SKF38393 or acetylcholine (ACh). Then we observed the subcellular distributions of the tagged receptors under the confocal microscopy and tried to determine trafficking properties by comparing their distribution patterns before and after the drug treatment.
RESULTSIn resting conditions, D1 receptors located in the plasma membrane of NG108-15 cells, while D5 receptors located in both plasma membrane and cytosol. With the pre-treatment of SKF38393, the subcellular distribution of D1 receptors was changed. The yellow particle-like fluorescence of tagged D1 receptors appeared in the cytosol, indicating that D1 receptors were internalized into cytosol from the cell surface. Same situation also occurred in ACh pre-treatment. In contrast, the subcellular distribution of D5 receptors was not changed after SKF38393 or ACh treatment, indicating that D5R was not translocated to cell surface. Interestingly, when D1 and D5 receptors were co-expressed in the same cell, both kept their distinct subcellular distribution patterns and the trafficking properties.
CONCLUSIONOur present study reveals that in NG108-15 nerve cells, dopamine D1 and D5 receptors exhibit differential subcellular distribution patterns, and only D1 receptor has a marked trafficking response to the drug stimulation. We further discuss the potential role of the differential trafficking properties of D1-like receptors in complex modulation of DA signaling.
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine ; pharmacology ; Acetylcholine ; pharmacology ; Animals ; Cell Line ; Dopamine Agonists ; pharmacology ; HeLa Cells ; Humans ; Luminescent Proteins ; genetics ; Mice ; Microscopy, Confocal ; methods ; Neuroblastoma ; Protein Transport ; drug effects ; Rats ; Receptors, Dopamine D1 ; metabolism ; Receptors, Dopamine D5 ; metabolism ; Subcellular Fractions ; metabolism ; ultrastructure ; Transfection ; methods
10.Expression of dopamine receptor D2 in pulmonary carcinoma cells and effects of dopamine on the cell apoptosis.
Yang-hong PENG ; Jing-ming ZHANG ; Nai-kang ZHOU ; Shan WANG
Journal of Southern Medical University 2011;31(6):975-978
OBJECTIVETo detect the expression of dopamine receptor D2 in different pulmonary carcinoma cells and investigate the effect of dopamine in inducing apoptosis of A549 cells.
METHODSWestern blotting and RT-PCR were employed to detect the expression of dopamine receptor D2 in different pulmonary carcinoma cells (95D, H460, GLC-82, A549 and H446 cells). The apoptosis of A549 cells after a 6-hour exposure to 0.02%, 0.04%, 0.08% and 0.1% dopamine was analyzed by flow cytometry. The apoptosis-inducing effect of dopamine in vivo was also tested by intratumoral injection of 1% dopamine in 2 BALB/c-nu mice bearing A549 tumor xenograft using flow cytometry.
RESULTSThe presence of dopamine receptor D2 expression was detected by Western blotting and RT-PCR in 95D, H460, GLC-82, A549 and H446 cells. Flow cytometry detected obvious apoptosis of A549 cells following dopamine exposure in vitro in positive correlation to dopamine concentration. In the tumor-bearing mice, dopamine also showed an obvious apoptosis-inducing effect on A549 cells.
CONCLUSIONDopamine receptor D2 exists extensively in different pulmonary carcinoma cells. Dopamine may promote the apoptosis of pulmonary carcinoma cells through dopamine receptor D2.
Adenocarcinoma ; metabolism ; pathology ; Animals ; Apoptosis ; drug effects ; Cell Line, Tumor ; Dopamine ; pharmacology ; Flow Cytometry ; Humans ; Lung Neoplasms ; metabolism ; pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Receptors, Dopamine D2 ; metabolism